The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Less than two weeks after the Senate moved to create a new prescription drug price cap system in Massachusetts, an industry official warned against legislative “leapfrog” that could ...

The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving ...

The FDA on June 2 launched a generative artificial intelligence tool agencywide to improve internal workflows and staff efficiency. Four things to know. 1. The AI tool, Elsa, is currently being used ...

In 2018, the FDA began an investigation into nitrosamine impurities in drugs that led to high-profile recalls for heartburn ...

Abstract: The semiconductor industry moves at a frantic pace ... meet the IEEE International Roadmap for Devices and Systems (IRDS).

The Pharmaceutical Wholesalers and Distributors Association of Nigeria has urged the Federal Government to implement the ...